Roderick Fields is a Rheumatology/Immunology physician affiliated with University of New Mexico. OpenAlex indexes 22 publications with 276 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2211 Lomas, NE
5th Floor-5acc
Albuquerque, NM 871060001
Telephone
505-272-3840Provider last certified this registry record 17 Jul 2025.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year20233 payments
- Amgen Inc.Program year20221 payment
- Amgen Inc.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
49.2%TNF inhibitor15.2%Humira(Cf) Pen40%Humira Pen27%Amjevita(Cf) Autoinjector14%Enbrel Sureclick10%Humira(Cf)9%Part D<11 patientsFolate Analog Metabolic Inhibitor13.6%Methotrexate100%Part D≥43 patients+ 8 more classes in this area
Antiparasitic
18.2%Antimalarial18.2%Hydroxychloroquine Sulfate100%Part D≥62 patientsMetabolism & gastrointestinal
17.4%Corticosteroid13.6%Prednisone100%Part D≥57 patientsAminosalicylate2.6%Sulfasalazine Dr100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Statin-associated immune-mediated necrotizing myopathy in Hispanic Americans
Seminars in Arthritis and Rheumatism
2025 - Scleroderma Renal Crisis and Musculoskeletal Corticosteroid Injections
JCR Journal of Clinical Rheumatology
2024 - 44124 Nonspecific cutaneous eruption in a patient with statin-associated autoimmune myopathy
Journal of the American Academy of Dermatology
2023 - Systemic sclerosis manifestations and clinical outcomes in Hispanics/Latinos of the American Southwest
Journal of Scleroderma and Related Disorders
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Mauricio Tohen, MD, DRPH, MBA
University of New Mexico
Howard Yonas, MD
University of New Mexico
Rhoshel Lenroot, MD
University of New Mexico
Mark Unruh, MD
University of New Mexico
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”